Similarly, immune/inflammation-related TFs, such as NFKB2, STAT1, and RELA, and FOXO3, showed high activity in CXCL10+MEL and TMSB4X+MEL subclusters, which underlies the immunomodulatory phenotype of tumor cells. This evidence concerns the gene TMSB4X and neoplasm.